JIP
IHI icon

Jaffetilchin Investment Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Jaffetilchin Investment Partners’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Sell
20,206
-1,425
-7% -$83.7K 0.06% 184
2025
Q4 		$1.34M Buy
21,631
+376
+2% +$23.2K 0.08% 159
2025
Q3 		$1.28M Sell
21,255
-841
-4% -$51.4K 0.08% 162
2025
Q2 		$1.38M Buy
22,096
+1,096
+5% +$65.9K 0.09% 146
2025
Q1 		$1.26M Sell
21,000
-179
-0.8% -$11.1K 0.09% 152
2024
Q4 		$1.24M Sell
21,179
-460
-2% -$27.3K 0.09% 142
2024
Q3 		$1.28M Sell
21,639
-3,600
-14% -$206K 0.1% 119
2024
Q2 		$1.41M Buy
25,239
+1,419
+6% +$79.4K 0.12% 104
2024
Q1 		$1.4M Buy
23,820
+491
+2% +$27.7K 0.13% 105
2023
Q4 		$1.26M Buy
23,329
+2,093
+10% +$102K 0.12% 113
2023
Q3 		$1.03M Buy
21,236
+797
+4% +$42.4K 0.11% 111
2023
Q2 		$1.15M Sell
20,439
-49,932
-71% -$2.75M 0.12% 111
2023
Q1 		$3.8M Buy
70,371
+757
+1% +$40.3K 0.43% 50
2022
Q4 		$3.66M Buy
69,614
+12,065
+21% +$612K 0.45% 54
2022
Q3 		$2.71M Buy
57,549
+14
+0% +$726 0.35% 47
2022
Q2 		$2.9M Buy
57,535
+47,944
+500% +$2.61M 0.34% 55
2022
Q1 		$492K Buy
9,591
+463
+5% +$27.6K 0.06% 187
2021
Q4 		$601K Buy
9,128
+7
+0.1% +$448 0.06% 188
2021
Q3 		$573K Sell
9,121
-9,113
-50% -$581K 0.06% 182
2021
Q2 		$1.05M Buy
18,234
+9,120
+100% +$527K 0.07% 165
2021
Q1 		$502K Hold
9,114
– – 0.06% 196
2020
Q4 		$497K Buy
9,114
+1,266
+16% +$66.2K 0.07% 162
2020
Q3 		$392K Sell
7,848
-1,050
-12% -$50.8K 0.07% 160
2020
Q2 		$393K Sell
8,898
-7,980
-47% -$341K 0.09% 149
2020
Q1 		$634K Buy
16,878
+5,826
+53% +$245K 0.22% 67
2019
Q4 		$487K Buy
11,052
+24
+0.2% +$1.01K 0.11% 125
2019
Q3 		$455K Sell
11,028
-672
-6% -$27.5K 0.11% 125
2019
Q2 		$469K Sell
11,700
-34,596
-75% -$1.31M 0.11% 135
2019
Q1 		$1.79M Buy
46,296
+8,964
+24% +$325K 0.4% 34
2018
Q4 		$1.24M Buy
37,332
+9,288
+33% +$322K 0.31% 46
2018
Q3 		$1.06M Buy
+28,044
New +$997K 0.22% 82

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jaffetilchin Investment Partners's IHI Position: Q1 2026 in Review

Jaffetilchin Investment Partners reduced its iShares US Medical Devices ETF (IHI) stake by 6.6% in Q1 2026, selling an estimated $83.7K and leaving 20,206 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #184.

Jaffetilchin Investment Partners first reported a position in IHI in Q3 2018 and has held it in 31 quarters since. The position peaked at $3.8M in Q1 2023. 507 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Jaffetilchin Investment Partners held 20,206 shares of iShares US Medical Devices ETF worth $1.08M as of Q1 2026.
  • Jaffetilchin Investment Partners sold 1,425 iShares US Medical Devices ETF shares in Q1 2026, an estimated $83.7K.
  • iShares US Medical Devices ETF made up 0.06% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #184 holding.
  • Jaffetilchin Investment Partners first reported a position in iShares US Medical Devices ETF in Q3 2018 and has held it in 31 quarters since.
  • Jaffetilchin Investment Partners's iShares US Medical Devices ETF position peaked at $3.8M in Q1 2023.
  • 507 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.